|
|
||||||||
|
FIGURE 5. Immunocytochemical staining of HUVECs. Monoclonal anti-VEGF receptor-2 (KDR) was used as the primary antibody. (A) Negative control. (B) Primary antibody.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |